tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

RVMD Stock Latest News

Revolution Medicines: Promising Phase 3 Progress and Strong RAS-ON Platform Drive Buy Rating
RatingsRevolution Medicines: Promising Phase 3 Progress and Strong RAS-ON Platform Drive Buy Rating
1d ago
RVMD
Revolution Medicines price target lowered to $64 from $78 at Stifel
PremiumThe Fly
Revolution Medicines price target lowered to $64 from $78 at Stifel
8d ago
RVMD
Erasca initiated with an Outperform at Raymond James
PremiumThe Fly
Erasca initiated with an Outperform at Raymond James
14d ago
ERAS
RVMD
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
PremiumThe Fly
Revolution Medicines price target raised to $73 from $72 at H.C. Wainwright
1M ago
RVMD
Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs
PremiumCompany Announcements
Revolution Medicines’ Earnings Call: Positive Progress Amid Rising Costs
1M ago
RVMD
Revolution Medicines Reports 2024 Financial Results and Progress
PremiumCompany AnnouncementsRevolution Medicines Reports 2024 Financial Results and Progress
1M ago
RVMD
Revolution Medicines reports Q4 EPS ($1.12), consensus (96c)
Premium
The Fly
Revolution Medicines reports Q4 EPS ($1.12), consensus (96c)
1M ago
RVMD
Revolution Medicines sees FY25 GAAP net loss $840M-$900M
Premium
The Fly
Revolution Medicines sees FY25 GAAP net loss $840M-$900M
1M ago
RVMD
RVMD Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
RVMD Upcoming Earnings Report: What to Expect?
1M ago
RVMD
Trump Trade: New administration to invest $20B to build data centers
PremiumThe Fly
Trump Trade: New administration to invest $20B to build data centers
3M ago
AMT
DLR
Revolution Medicines price target raised to $71 from $65 at UBS
PremiumThe Fly
Revolution Medicines price target raised to $71 from $65 at UBS
3M ago
RVMD
Revolution Medicines price target lowered to $62 from $68 at Needham
PremiumThe Fly
Revolution Medicines price target lowered to $62 from $68 at Needham
4M ago
RVMD
Revolution Medicines price target raised to $72 from $64 at H.C. Wainwright
PremiumThe FlyRevolution Medicines price target raised to $72 from $64 at H.C. Wainwright
4M ago
RVMD
Revolution Medicines 14.13M share Secondary priced at $46.00
Premium
The Fly
Revolution Medicines 14.13M share Secondary priced at $46.00
4M ago
RVMD
Revolution Medicines price target raised to $87 from $82 at Guggenheim
Premium
The Fly
Revolution Medicines price target raised to $87 from $82 at Guggenheim
4M ago
RVMD
Revolution Medicines price target raised to $71 from $63 at JPMorgan
PremiumThe Fly
Revolution Medicines price target raised to $71 from $63 at JPMorgan
4M ago
RVMD
Revolution Medicines announces $600M common stock offering
PremiumThe Fly
Revolution Medicines announces $600M common stock offering
4M ago
RVMD
Revolution Medicines price target raised to $80 from $70 at Stifel
PremiumThe Fly
Revolution Medicines price target raised to $80 from $70 at Stifel
4M ago
RVMD
Revolution Medicines provides updates from RAS(ON) inhibitor combo studies
PremiumThe Fly
Revolution Medicines provides updates from RAS(ON) inhibitor combo studies
4M ago
RVMD
Revolution Medicines provides updates from RAS(ON) inhibitor portfolio
PremiumThe FlyRevolution Medicines provides updates from RAS(ON) inhibitor portfolio
4M ago
RVMD
Erasca initiated with a Buy at Jefferies
Premium
The Fly
Erasca initiated with a Buy at Jefferies
5M ago
ERAS
RVMD
Revolution Medicines price target raised to $70 from $57 at Piper Sandler
Premium
The Fly
Revolution Medicines price target raised to $70 from $57 at Piper Sandler
5M ago
RVMD

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >